Mi‐Jin Sohn

Statistics

Publications

Citations

816

H-Index

Active since

2001

Affiliations

Korea Research Institute of Bioscience and Biotechnology(Current)

Seoul National University

McLean Hospital

Korea Advanced Institute of Science and Technology

Harvard University

Mi‐Jin Sohn is an author at Korea Research Institute of Bioscience and Biotechnology specializing in medicine, pharmacology, and antimicrobial resistance.

Top concepts

MedicinePharmacologyBiochemistryMicrobiologyAntimicrobial ResistanceAntibioticsDrug DiscoveryDrug ResistanceNatural SciencesNeurology

Publications per year

2001–2016

Publications

Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson’s disease

Chun‐Hyung Kim, Baek‐Soo Han, Jisook Moon et al. · Proceedings of the National Academy of Sciences · 2015 · 190 citations · Full text

Isolation and identification of pentagalloylglucose with broad-spectrum antibacterial activity from Rhus trichocarpa Miquel

Jun‐Young Cho, Mi‐Jin Sohn, Joongku Lee et al. · Food Chemistry · 2010 · 55 citations

Bioorganic Chemistry, Bioassay-guided Isolation, Medicine +8

Flavimycins A and B, Dimeric 1,3-Dihydroisobenzofurans with Peptide Deformylase Inhibitory Activity from <i>Aspergillus flavipes</i>

Yun‐Ju Kwon, Mi‐Jin Sohn, Chang‐Jin Kim et al. · Journal of Natural Products · 2012 · 55 citations · Full text

Atromentin and Leucomelone, the First Inhibitors Specific to Enoyl-ACP Reductase (FabK) of Streptococcus pneumoniae

Chang‐Ji Zheng, Mi‐Jin Sohn, Won‐Gon Kim · The Journal of Antibiotics · 2006 · 54 citations · Full text

Streptococcus Pneumoniae, Antimicrobial Susceptibility, Health Sciences +12

Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action

Chang Ji Zheng, Mi‐Jin Sohn, Sangku Lee et al. · PLoS ONE · 2013 · 52 citations · Full text

New Fabi Inhibitor, Medicinal Fungi, S. Aureus Fabi +21

1–5 of 19